ALTA3263 drug page Clinical trials

Trials with ALTA3263

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
448Planned patients

Showing 1–1 of 1

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recruiting Phase 1 448 patients NCT06835569

The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.

United States Mar 2025 – Aug 2029 Interventional

Where the recruiting trials are